📰 Naomi Eichenbaum News
Page 4 - Naomi Eichenbaum News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Naomi Eichenbaum. Real-time updates on events, politics, business and more.
February 17, 2023
First single molecule Dual Endothelin Angiotensin Receptor Antagonist (DEARA) approved for use in patients withIgA nephropathy (IgAN)Interim results from...
January 13, 2023
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on January 10, 2023, the Compensation...
August 30, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
August 30, 2022
-- 12 to 61-fold increase in neutralizing antibodies against BA.5 among participants receiving SCB-2019 (CpG 1018/Alum) as a homologous third dose or with...
June 27, 2022
SCB-2019 (CpG 1018/Alum) as a third dose exhibited a 19-fold boost in neutralizing antibodies against Omicron BA.2 variant among baseline seronegative...
May 31, 2022
--Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as a 2-dose vaccination series in adults----SCB-
May 17, 2022
17.05.2022 - SHANGHAI, China, May 17, 2022 (GLOBE NEWSWIRE) - Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced its participation ...
April 30, 2022
Clover Appoints LiongHo Chua as President of Greater China GlobeNewswire April 27, 2022 SHANGHAI, China, April 27, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Mr. LiongHo Chua as President of Greater China....
April 27, 2022
Clover Appoints LiongHo Chua as President of Greater China - read this article along with other careers information, tips and advice on BioSpace
March 17, 2022
--Significant neutralizing antibodies against Omicron induced by SCB-2019 third dose in both homologous and heterologous booster settings-- Clover Biopharmaceuticals, Ltd. , a global... | March 17, 2022